{"id":"https://openalex.org/W2292173227","doi":"https://doi.org/10.1182/blood.v86.3.1027.1027","title":"Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory- type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia","display_name":"Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory- type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia","publication_year":1995,"publication_date":"1995-08-01","ids":{"openalex":"https://openalex.org/W2292173227","doi":"https://doi.org/10.1182/blood.v86.3.1027.1027","mag":"2292173227","pmid":"https://pubmed.ncbi.nlm.nih.gov/7620156"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v86.3.1027.1027","doi":"https://doi.org/10.1182/blood.v86.3.1027.1027","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v86.3.1027.1027","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062464380","display_name":"Patty M. Jansen","orcid":"https://orcid.org/0000-0002-2361-9303","observed_orcids":["https://orcid.org/0000-0002-2361-9303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"PM Jansen","raw_affiliation_strings":["Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022879436","display_name":"Marja A. Boermeester","orcid":"https://orcid.org/0000-0003-3890-8105","observed_orcids":["https://orcid.org/0000-0003-3890-8105","https://orcid.org/0000-0001-5941-5444"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MA Boermeester","raw_affiliation_strings":["Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022445571","display_name":"E Fischer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Fischer","raw_affiliation_strings":["Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020967785","display_name":"IW de Jong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"IW de Jong","raw_affiliation_strings":["Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048965254","display_name":"Tom van der Poll","orcid":"https://orcid.org/0000-0002-9199-5079","observed_orcids":["https://orcid.org/0000-0002-9199-5079"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T van der Poll","raw_affiliation_strings":["Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081164839","display_name":"Lyle L. Moldawer","orcid":"https://orcid.org/0000-0002-9041-9838","observed_orcids":["https://orcid.org/0000-0002-9041-9838"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LL Moldawer","raw_affiliation_strings":["Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080558143","display_name":"C. Erik Hack","orcid":"https://orcid.org/0009-0000-7281-8002","observed_orcids":["https://orcid.org/0009-0000-7281-8002"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"CE Hack","raw_affiliation_strings":["Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113917772","display_name":"SF Lowry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SF Lowry","raw_affiliation_strings":["Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":4.3562,"has_fulltext":false,"cited_by_count":98,"citation_normalized_percentile":{"value":0.94442729,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"86","issue":"3","first_page":"1027","last_page":"1034"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14165","display_name":"Inflammation biomarkers and pathways","score":0.05260000005364418,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.012400000356137753,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-1-alpha","display_name":"interleukin-1 alpha","score":0.9580000042915344},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.9380000233650208},{"id":"https://openalex.org/keywords/coagulation-activation","display_name":"coagulation activation","score":0.8799999952316284},{"id":"https://openalex.org/keywords/fibrinolysis","display_name":"fibrinolysis","score":0.996999979019165},{"id":"https://openalex.org/keywords/neutrophil-degranulation","display_name":"neutrophil degranulation","score":0.8880000114440918},{"id":"https://openalex.org/keywords/thrombin","display_name":"thrombin","score":0.6949999928474426},{"id":"https://openalex.org/keywords/tissue-plasminogen-activator","display_name":"tissue plasminogen activator","score":0.9380000233650208},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor","display_name":"plasminogen activator inhibitor","score":0.9750000238418579},{"id":"https://openalex.org/keywords/interleukin-1-receptor-antagonist","display_name":"interleukin-1 receptor antagonist","score":0.8759999871253967},{"id":"https://openalex.org/keywords/escherichia-coli-bacteremia","display_name":"Escherichia coli bacteremia","score":0.9129999876022339},{"id":"https://openalex.org/keywords/baboons","display_name":"baboons","score":0.7519999742507935}],"concepts":[{"id":"https://openalex.org/C2776825266","wikidata":"https://www.wikidata.org/wiki/Q1410794","display_name":"Fibrinolysis","level":2,"score":0.7100837826728821},{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.5784679651260376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5593050718307495},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5284538269042969},{"id":"https://openalex.org/C2781071845","wikidata":"https://www.wikidata.org/wiki/Q21173374","display_name":"Plasmin","level":3,"score":0.4864959120750427},{"id":"https://openalex.org/C2909373784","wikidata":"https://www.wikidata.org/wiki/Q416351","display_name":"T-plasminogen activator","level":3,"score":0.4796467423439026},{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.47110942006111145},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.4680706262588501},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4305562376976013},{"id":"https://openalex.org/C49802076","wikidata":"https://www.wikidata.org/wiki/Q5251810","display_name":"Degranulation","level":3,"score":0.42457136511802673},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4178309142589569},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.41560235619544983},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4126015901565552},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3990834653377533},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.3391087055206299},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2200789749622345},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09307286143302917},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.08363017439842224},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005342","descriptor_name":"Fibrinolysis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010215","descriptor_name":"Papio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010741","descriptor_name":"Phospholipases A","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D012795","descriptor_name":"Sialoglycoproteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015550","descriptor_name":"Cell Degranulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017472","descriptor_name":"Receptors, Interleukin-1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017472","descriptor_name":"Receptors, Interleukin-1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D053590","descriptor_name":"Interleukin 1 Receptor Antagonist Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054467","descriptor_name":"Phospholipases A2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1182/blood.v86.3.1027.1027","doi":"https://doi.org/10.1182/blood.v86.3.1027.1027","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v86.3.1027.1027","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"doi:10.1182/blood.v86.3.1027.bloodjournal8631027","doi":"https://doi.org/10.1182/blood.v86.3.1027.bloodjournal8631027","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v86.3.1027.bloodjournal8631027","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:7620156","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7620156","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.880.2036","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.880.2036","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.bloodjournal.org/content/bloodjournal/86/3/1027.full.pdf?sso-checked%3Dtrue","raw_type":"text"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/cf1a3efa-855b-4382-beea-2adf239e1082","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/contribution-of-interleukin1-to-activation-of-coagulation-and-fibrinolysis-neutrophil-degranulation-and-the-release-of-secretorytype-phospholipase-a2-in-sepsis-studies-in-nonhuman-primates-after-interleukin1-alpha-administration-and-during-lethal-bacteremia(cf1a3efa-855b-4382-beea-2adf239e1082).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 86(3), 1027 - 1034. American Society of Hematology","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/e1139b56-d115-4ef6-b527-a2c2b72e7132","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/e1139b56-d115-4ef6-b527-a2c2b72e7132","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Jansen, P M, Boermeester, M A, Fischer, E, de Jong, I W, van der Poll, T, Moldawer, L L, Hack, C E & Lowry, S F 1995, 'Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia', Blood, vol. 86, no. 3, pp. 1027-1034.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G60488670","display_name":null,"funder_award_id":"GM40586","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G8827484449","display_name":"CYTOKINES AS ENDOGENOUS MEDIATORS OF CANCER CACHEXIA","funder_award_id":"R01CA052108","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W136462","https://openalex.org/W20481197","https://openalex.org/W79103623","https://openalex.org/W114205036","https://openalex.org/W1030359021","https://openalex.org/W1497298414","https://openalex.org/W1527174508","https://openalex.org/W1574330564","https://openalex.org/W1595391532","https://openalex.org/W1641540149","https://openalex.org/W1659985814","https://openalex.org/W1805766162","https://openalex.org/W1864963307","https://openalex.org/W1962917559","https://openalex.org/W1969719203","https://openalex.org/W1982765934","https://openalex.org/W1988219230","https://openalex.org/W1988243363","https://openalex.org/W1992644897","https://openalex.org/W2009764505","https://openalex.org/W2033727773","https://openalex.org/W2037872670","https://openalex.org/W2040930510","https://openalex.org/W2060724258","https://openalex.org/W2110623508","https://openalex.org/W2149349927","https://openalex.org/W2150608680","https://openalex.org/W2152088076","https://openalex.org/W2181624522","https://openalex.org/W2213677741","https://openalex.org/W2267848767","https://openalex.org/W2336770370","https://openalex.org/W2339475902","https://openalex.org/W2398562114","https://openalex.org/W2413809587","https://openalex.org/W2417093506","https://openalex.org/W2417221154","https://openalex.org/W2473018290","https://openalex.org/W4237524633"],"related_works":["https://openalex.org/W7096343363","https://openalex.org/W1965340334","https://openalex.org/W2441859652","https://openalex.org/W2417221154","https://openalex.org/W1989951338","https://openalex.org/W2071258337","https://openalex.org/W2031364456","https://openalex.org/W2087270937","https://openalex.org/W2518474695","https://openalex.org/W2104631810"],"abstract_inverted_index":{"Although":[0],"studies":[1],"with":[2,94],"interleukin-1":[3],"receptor":[4],"antagonist":[5],"(IL-1ra)":[6],"in":[7,17,77,89,298,317,330,344,349,358,365,381,384,399,410],"animal":[8],"models":[9],"have":[10],"shown":[11],"that":[12,34,305,389],"IL-1":[13,22,35,69,115,372,398,409],"contributes":[14,373],"to":[15,249,269,289,304,374],"mortality":[16],"sepsis,":[18],"the":[19,37,62,83,120,127,135,149,173,210,229,236,257,299,350,394],"mechanisms":[20],"whereby":[21],"mediates":[23],"lethal":[24,96,395],"effects":[25,391],"are":[26],"not":[27,224,369],"well":[28,147],"established.":[29],"A":[30],"possible":[31],"mechanism":[32],"is":[33],"enhances":[36],"activation":[38,150,375],"and":[39,51,101,189,277,325,332,403],"release":[40,174,211,258,309],"of":[41,64,85,98,108,114,122,129,151,166,175,212,226,235,238,259,310,376,397],"other":[42,378],"inflammatory":[43,87],"mediator":[44,379],"systems":[45,380],"such":[46],"as":[47,124,146,148],"coagulation,":[48],"fibrinolysis,":[49,152],"neutrophils,":[50],"secretory-type":[52],"phospholipase":[53],"A2":[54],"(sPLA2).":[55],"We":[56,387],"investigated":[57],"this":[58,400],"possibility":[59],"by":[60,126,154],"assessing":[61],"effect":[63],"intravenously":[65],"injected":[66],"recombinant":[67],"human":[68,412],"alpha":[70,116,206],"(rhIL-1":[71],"alpha)":[72],"on":[73],"these":[74,86,390],"plasma":[75,169],"parameters":[76,88],"baboons.":[78],"In":[79,228],"addition,":[80],"we":[81],"examined":[82],"course":[84],"baboons":[90],"after":[91],"a":[92,95,104,232,405],"challenge":[93],"dose":[97],"Escherichia":[99],"coli":[100],"while":[102],"receiving":[103,301,306],"24-hour":[105],"constant":[106],"infusion":[107],"IL-1ra":[109,302],"or":[110],"placebo.":[111,307],"Intravenous":[112],"administration":[113,207],"(10":[117],"micrograms/kg)":[118],"induced":[119,209],"formation":[121,237],"thrombin,":[123],"evidenced":[125],"appearance":[128],"thrombin-antithrombin":[130],"III":[131],"(TAT)":[132],"complexes":[133,158],"into":[134],"circulation":[136],"(peak":[137,240,261,281,320],"levels,":[138,162,181,197,215,321,353],"188":[139],"+/-":[140,164,183,199,217,246,251,266,271,286,291,323,327,355,362],"92":[141],"ng/mL":[142,185,201,219,248,268,288,329,357,364],"at":[143,170,186,202,220],"2":[144,184,187,272],"hours),":[145,188,222],"assessed":[153],"circulating":[155],"plasmin-alpha":[156],"2-antiplasmin":[157],"(PAP":[159],"complexes;":[160],"peak":[161,180,196],"0.4%":[163],"0.03%":[165],"fully":[167],"activated":[168],"1":[171],"hour),":[172],"tissue-type":[176],"plasminogen":[177,192],"activator":[178,193],"(t-PA;":[179],"6":[182],"its":[190,278],"inhibitor,":[191,279],"inhibitor":[194],"(PAI;":[195],"724":[198],"246":[200],"4":[203],"hours).":[204],"Il-1":[205],"also":[208,314],"sPLA2":[213,342],"(maximal":[214,352],"336":[216],"185":[218],"8":[221],"but":[223],"degranulation":[225],"neutrophils.":[227],"septic":[230],"baboons,":[231],"significant":[233],"reduction":[234],"thrombin":[239],"TAT":[241],"levels":[242,262,282,343],"decreased":[243,263,283],"from":[244,264,284],"582":[245],"78":[247],"219":[250],"106":[252],"ng/mL;":[253,273,293],"P":[254,274,294,336],"<":[255,275,337],".005),":[256],"t-PA":[260],"37":[265],"11":[267],"17":[270],".001),":[276],"PAI":[280],"2,639":[285],"974":[287],"1,110":[290],"153":[292],"<.001),":[295],"was":[296,313,368],"observed":[297],"group":[300],"compared":[303],"The":[308,339],"neutrophilic":[311],"elastase":[312],"significantly":[315],"attenuated":[316],"IL-1a-treated":[318],"animals":[319],"1,024":[322],"393":[324],"655":[326],"104":[328],"control":[331,359],"treatment":[333],"groups,":[334,346],"respectively;":[335],".05).":[338],"difference":[340],"between":[341],"both":[345],"although":[347],"higher":[348],"controls":[351],"3,140":[354],"1,435":[356],"v":[360],"2,217":[361],"1,375":[363],"IL-1ra-treated":[366],"group),":[367],"significant.":[370],"Thus,":[371],"various":[377],"severe":[382,411],"sepsis":[383,401],"nonhuman":[385],"primates.":[386],"propose":[388],"may":[392],"explain":[393],"actions":[396],"model":[402],"suggest":[404],"similar":[406],"role":[407],"for":[408],"sepsis.":[413]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}